# Gibraltar Industries, Inc.: financial statements, quarterly

ROCK · Nasdaq · CIK 912562 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rock.md) · [Financials](/companies/rock/financials.md) · [Filings](/companies/rock/filings.md) · [Insiders](/companies/rock/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rock/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [391](/filings/0000912562-24-000061.md) | [(1.9) d](/filings/0000912562-26-000025.md) | [293](/filings/0000912562-25-000020.md) | [274](/filings/0000912562-25-000035.md) | [277](/filings/0000912562-25-000054.md) | [232 d](/filings/0000912562-26-000025.md) | [246](/filings/0000912562-26-000094.md) | [310](/filings/0000912562-26-000147.md) | [311](/filings/0000912562-25-000054.md) | [269 d](/filings/0000912562-26-000025.md) | [356](/filings/0000912562-26-000094.md) | [510](/filings/0000912562-26-000147.md) |
| Cost of revenue | $m | [285](/filings/0000912562-24-000061.md) | [(4.7) d](/filings/0000912562-26-000025.md) | [208](/filings/0000912562-25-000020.md) | [190](/filings/0000912562-25-000035.md) | [196](/filings/0000912562-25-000054.md) | [167 d](/filings/0000912562-26-000025.md) | [177](/filings/0000912562-26-000094.md) | [222](/filings/0000912562-26-000147.md) | [228](/filings/0000912562-25-000054.md) | [204 d](/filings/0000912562-26-000025.md) | [277](/filings/0000912562-26-000094.md) | [377](/filings/0000912562-26-000147.md) |
| Gross profit | $m | [105](/filings/0000912562-24-000061.md) | [2.8 d](/filings/0000912562-26-000025.md) | [84.4](/filings/0000912562-25-000020.md) | [83.3](/filings/0000912562-25-000035.md) | [81.4](/filings/0000912562-25-000054.md) | [64.6 d](/filings/0000912562-26-000025.md) | [69.9](/filings/0000912562-26-000094.md) | [87.8](/filings/0000912562-26-000147.md) | [82.7](/filings/0000912562-25-000054.md) | [64.8 d](/filings/0000912562-26-000025.md) | [78.9](/filings/0000912562-26-000094.md) | [132](/filings/0000912562-26-000147.md) |
| Selling, general and administrative | $m | [52.2](/filings/0000912562-24-000061.md) | [4.7 d](/filings/0000912562-26-000025.md) | [52.7](/filings/0000912562-25-000020.md) | [42.5](/filings/0000912562-25-000035.md) | [38.2](/filings/0000912562-25-000054.md) | [33.0 d](/filings/0000912562-26-000025.md) | [41.2](/filings/0000912562-26-000094.md) | [48.3](/filings/0000912562-26-000147.md) | [42.8](/filings/0000912562-25-000054.md) | [50.1 d](/filings/0000912562-26-000025.md) | [83.3](/filings/0000912562-26-000094.md) | [72.3](/filings/0000912562-26-000147.md) |
| Operating income | $m | [53.2](/filings/0000912562-24-000061.md) | [(5.1) d](/filings/0000912562-26-000025.md) | [31.7](/filings/0000912562-25-000020.md) | [40.8](/filings/0000912562-25-000035.md) | [43.2](/filings/0000912562-25-000054.md) | [25.6 d](/filings/0000912562-26-000025.md) | [28.7](/filings/0000912562-26-000094.md) | [39.5](/filings/0000912562-26-000147.md) | [39.9](/filings/0000912562-25-000054.md) | [14.6 d](/filings/0000912562-26-000025.md) | [(4.5)](/filings/0000912562-26-000094.md) | [59.8](/filings/0000912562-26-000147.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [14.5](/filings/0000912562-24-000061.md) | [(1.0) d](/filings/0000912562-26-000025.md) | [8.6](/filings/0000912562-25-000020.md) | [11.1](/filings/0000912562-25-000035.md) | [10.9](/filings/0000912562-25-000054.md) | [5.7 d](/filings/0000912562-26-000025.md) | [7.1](/filings/0000912562-26-000094.md) | [9.8](/filings/0000912562-26-000147.md) | [8.7](/filings/0000912562-25-000054.md) | [3.4 d](/filings/0000912562-26-000025.md) | [(4.6)](/filings/0000912562-26-000094.md) | [10.6](/filings/0000912562-26-000147.md) |
| Net income | $m | [39.3](/filings/0000912562-24-000061.md) | [19.4 d](/filings/0000912562-26-000025.md) | [24.9](/filings/0000912562-25-000020.md) | [32.2](/filings/0000912562-25-000035.md) | [34.0](/filings/0000912562-25-000054.md) | [46.2 d](/filings/0000912562-26-000025.md) | [21.1](/filings/0000912562-26-000094.md) | [26.0](/filings/0000912562-26-000147.md) | [(89.1)](/filings/0000912562-25-000054.md) | [(2.4) d](/filings/0000912562-26-000025.md) | [(67.5)](/filings/0000912562-26-000094.md) | [8.2](/filings/0000912562-26-000147.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [1.05](/filings/0000912562-25-000035.md) | [1.11](/filings/0000912562-25-000054.md) | not reported | [0.69](/filings/0000912562-26-000094.md) | [0.87](/filings/0000912562-26-000147.md) | [(2.98)](/filings/0000912562-25-000054.md) | not reported | [(2.26)](/filings/0000912562-26-000094.md) | [0.28](/filings/0000912562-26-000147.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [1.05](/filings/0000912562-25-000035.md) | [1.11](/filings/0000912562-25-000054.md) | not reported | [0.70](/filings/0000912562-26-000094.md) | [0.87](/filings/0000912562-26-000147.md) | [(2.99)](/filings/0000912562-25-000054.md) | not reported | [(2.26)](/filings/0000912562-26-000094.md) | [0.28](/filings/0000912562-26-000147.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [85.5](/filings/0000912562-23-000046.md) | [99.4](/filings/0000912562-25-000007.md) | [147](/filings/0000912562-24-000028.md) | [179](/filings/0000912562-24-000045.md) | [229](/filings/0000912562-24-000061.md) | [269](/filings/0000912562-26-000025.md) | [25.1](/filings/0000912562-25-000020.md) | [43.3](/filings/0000912562-25-000035.md) | [89.4](/filings/0000912562-25-000054.md) | [116](/filings/0000912562-26-000147.md) | [20.3](/filings/0000912562-26-000094.md) | [15.1](/filings/0000912562-26-000147.md) |
| Current assets | $m | [508](/filings/0000912562-23-000046.md) | [462](/filings/0000912562-25-000007.md) | [531](/filings/0000912562-24-000028.md) | [592](/filings/0000912562-24-000045.md) | [642](/filings/0000912562-24-000061.md) | [651](/filings/0000912562-26-000025.md) | [473](/filings/0000912562-25-000020.md) | [754](/filings/0000912562-25-000035.md) | [695](/filings/0000912562-25-000054.md) | [629](/filings/0000912562-26-000147.md) | [700](/filings/0000912562-26-000094.md) | [712](/filings/0000912562-26-000147.md) |
| Total assets | $m | [1,288](/filings/0000912562-23-000046.md) | [1,256](/filings/0000912562-25-000007.md) | [1,320](/filings/0000912562-24-000028.md) | [1,377](/filings/0000912562-24-000045.md) | [1,425](/filings/0000912562-24-000061.md) | [1,419](/filings/0000912562-26-000025.md) | [1,439](/filings/0000912562-25-000020.md) | [1,483](/filings/0000912562-25-000035.md) | [1,438](/filings/0000912562-25-000054.md) | [1,394](/filings/0000912562-26-000147.md) | [2,787](/filings/0000912562-26-000094.md) | [2,786](/filings/0000912562-26-000147.md) |
| Current liabilities | $m | [313](/filings/0000912562-23-000046.md) | [226](/filings/0000912562-25-000007.md) | [264](/filings/0000912562-24-000028.md) | [285](/filings/0000912562-24-000045.md) | [307](/filings/0000912562-24-000061.md) | [255](/filings/0000912562-26-000025.md) | [277](/filings/0000912562-25-000020.md) | [296](/filings/0000912562-25-000035.md) | [388](/filings/0000912562-25-000054.md) | [366](/filings/0000912562-26-000147.md) | [497](/filings/0000912562-26-000094.md) | [489](/filings/0000912562-26-000147.md) |
| Long-term debt | $m | [0.0](/filings/0000912562-23-000046.md) | [0.0](/filings/0000912562-24-000012.md) | [0.0](/filings/0000912562-24-000028.md) | [0.0](/filings/0000912562-24-000045.md) | [0.0](/filings/0000912562-24-000061.md) | [0.0](/filings/0000912562-26-000025.md) | [0.0](/filings/0000912562-25-000020.md) | [0.0](/filings/0000912562-25-000035.md) | [0.0](/filings/0000912562-25-000054.md) | [0.0](/filings/0000912562-26-000147.md) | [1,221](/filings/0000912562-26-000094.md) | [1,218](/filings/0000912562-26-000147.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000912562-26-000094.md) | [0.0](/filings/0000912562-26-000147.md) |
| Shareholders' equity | $m | [890](/filings/0000912562-24-000061.md) | [915](/filings/0000912562-26-000025.md) | [940](/filings/0000912562-25-000035.md) | [976](/filings/0000912562-25-000054.md) | [1,003](/filings/0000912562-25-000054.md) | [1,048](/filings/0000912562-26-000147.md) | [1,009](/filings/0000912562-26-000147.md) | [1,041](/filings/0000912562-26-000147.md) | [952](/filings/0000912562-25-000054.md) | [950](/filings/0000912562-26-000147.md) | [881](/filings/0000912562-26-000147.md) | [891](/filings/0000912562-26-000147.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [92.6 d](/filings/0000912562-24-000061.md) | [11.8 d](/filings/0000912562-26-000025.md) | [53.2](/filings/0000912562-25-000020.md) | [36.5 d](/filings/0000912562-25-000035.md) | [64.7 d](/filings/0000912562-25-000054.md) | [19.9 d](/filings/0000912562-26-000025.md) | [13.7](/filings/0000912562-26-000094.md) | [44.9 d](/filings/0000912562-26-000147.md) | [73.0 d](/filings/0000912562-25-000054.md) | [35.5 d](/filings/0000912562-26-000025.md) | [(41.2)](/filings/0000912562-26-000094.md) | [3.8 d](/filings/0000912562-26-000147.md) |
| Capital expenditure | $m | [2.7 d](/filings/0000912562-24-000061.md) | [5.9 d](/filings/0000912562-26-000025.md) | [4.4](/filings/0000912562-25-000020.md) | [3.0 d](/filings/0000912562-25-000035.md) | [4.2 d](/filings/0000912562-25-000054.md) | [5.9 d](/filings/0000912562-26-000025.md) | [10.8](/filings/0000912562-26-000094.md) | [18.2 d](/filings/0000912562-26-000147.md) | [8.2 d](/filings/0000912562-25-000054.md) | [9.2 d](/filings/0000912562-26-000025.md) | [6.0](/filings/0000912562-26-000094.md) | [5.2 d](/filings/0000912562-26-000147.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.4 d](/filings/0000912562-24-000061.md) | [0.1 d](/filings/0000912562-26-000025.md) | [1.4](/filings/0000912562-25-000020.md) | [0.0 d](/filings/0000912562-25-000035.md) | [9.5 d](/filings/0000912562-25-000054.md) | [1.2 d](/filings/0000912562-26-000025.md) | [62.4](/filings/0000912562-26-000094.md) | [0.1 d](/filings/0000912562-26-000147.md) | [1.2 d](/filings/0000912562-25-000054.md) | [0.1 d](/filings/0000912562-26-000025.md) | [3.9](/filings/0000912562-26-000094.md) | [0.1 d](/filings/0000912562-26-000147.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [31.8](/filings/0000912562-23-000046.md) | [31.0](/filings/0000912562-24-000028.md) | [30.7](/filings/0000912562-24-000045.md) | [30.7](/filings/0000912562-24-000061.md) | [30.8](/filings/0000912562-25-000020.md) | [30.8](/filings/0000912562-25-000035.md) | [30.8](/filings/0000912562-25-000054.md) | [30.5](/filings/0000912562-26-000094.md) | [29.8](/filings/0000912562-26-000147.md) | [29.9](/filings/0000912562-25-000054.md) | [29.8](/filings/0000912562-26-000094.md) | [29.8](/filings/0000912562-26-000147.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,683,889 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0000912562-26-000147.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.